Home › NDC Lookup › RxCUI directory › RxCUI 897640

Verapamil hydrochloride 180 MG Extended Release Oral Tablet — RxCUI 897640

RxNorm drug concept · Semantic clinical drug
RxCUI 897640 Semantic clinical drug · SCD ● Current RxNorm concept 23 FDA products 45 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI897640
Official nameVerapamil hydrochloride 180 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asverapamil HCl 180 MG Extended Release Oral Tablet
FDA products mapped23
Package NDCs mapped45
Reported Medicaid activity (SDUD)51,293 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Verapamil: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Verapamil tablets treat angina, certain fast heart rhythms and high blood pressure. Extended-release forms are used for high blood pressure. The injectio...
  • Extended-release tablets are taken with food in the morning. The PM capsules are taken at bedtime. Swallow capsules whole, or sprinkle the entire contents on applesauce. Never crus...
  • How should I take my extended-release verapamil?
  • Constipation is the most common, along with headache, dizziness and ankle swelling. Tell your doctor if they bother you. Call right away for fainting, a very slow heartbeat, shortn...
📖 Read our full Verapamil guide →

🕸️ Concept Web — How Verapamil hydrochloride 180 MG Extended Release... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Verapamil hydrochloride 180 MG Extended Release Oral Tablet RxCUI 897640

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Verapamil 11170
    • Verapamil hydrochloride 203138
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Calan 203490
    • Isoptin 203489
  3. Dose forms 17

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Verapamil Extended Release Oral Tablet 374290
    • Verapamil hydrochloride Extended Release Oral Tablet 2645399
    • Verapamil Oral Product 1160512
    • Verapamil Pill 1160513
    • Verapamil hydrochloride Oral Product 2660958
    • Verapamil hydrochloride Pill 2659127
    • Verapamil Extended Release Oral Tablet [Calan] 885399
    • Verapamil Extended Release Oral Tablet [Isoptin] 876534
    • +9 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Verapamil hydrochloride 180 MG 897617
    • Verapamil hydrochloride 180 MG Extended Release Oral Tablet [Calan] 897676
    • Verapamil hydrochloride 180 MG Extended Release Oral Tablet [Isoptin] 897700
    • Verapamil hydrochloride 180 MG [Calan] 897675
    • Verapamil hydrochloride 180 MG [Isoptin] 897699

Showing up to 8 concepts per family — 17 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Verapamil hydrochloride 180 MG SCDC · 897617
  • Verapamil Extended Release Oral Tablet SCDF · 374290
  • Verapamil hydrochloride Extended Release Oral Tablet SCDFP · 2645399
  • Verapamil Oral Product SCDG · 1160512
  • Verapamil Pill SCDG · 1160513
  • Verapamil hydrochloride Oral Product SCDGP · 2660958
  • Verapamil hydrochloride Pill SCDGP · 2659127

Brand-Name Concepts

  • Verapamil hydrochloride 180 MG Extended Release Oral Tablet [Calan] SBD · 897676
  • Verapamil hydrochloride 180 MG Extended Release Oral Tablet [Isoptin] SBD · 897700
  • Verapamil hydrochloride 180 MG [Calan] SBDC · 897675
  • Verapamil hydrochloride 180 MG [Isoptin] SBDC · 897699
  • Verapamil Extended Release Oral Tablet [Calan] SBDF · 885399
  • Verapamil Extended Release Oral Tablet [Isoptin] SBDF · 876534
  • Verapamil hydrochloride Extended Release Oral Tablet [Calan] SBDFP · 2654905
  • Verapamil hydrochloride Extended Release Oral Tablet [Isoptin] SBDFP · 2657393
  • Calan Oral Product SBDG · 1170878
  • Calan Pill SBDG · 1170879

📦 FDA Products & Package NDCs

23 products · 45 package NDCs
45 package NDCs map to RxCUI 897640 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50090-5253-04 30 TABLET in 1 BOTTLE (50090-5253-4) VERAPAMIL HYDROCHLORIDE A-S Medication Solutions 2020-10-14
51655-0734-52 30 TABLET in 1 BOTTLE, PLASTIC (51655-734-52) VERAPAMIL HYDROCHLORIDE Northwind Health Company, LLC 2021-06-17
51655-0959-52 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... verapamil hydrochloride Northwind Health Company, LLC 2023-01-31
68071-3436-00 100 TABLET in 1 BOTTLE (68071-3436-0) VERAPAMIL HYDROCHLORIDE NuCare Pharmaceuticals,Inc. 2023-06-09
68071-5257-09 90 TABLET in 1 BOTTLE (68071-5257-9) VERAPAMIL HYDROCHLORIDE NuCare Pharmaceuticals,Inc. 2020-05-13
68382-0561-01 100 TABLET in 1 BOTTLE (68382-561-01) Verapamil hydrochloride Zydus Pharmaceuticals (USA) Inc. 2026-05-21
68382-0561-05 500 TABLET in 1 BOTTLE (68382-561-05) Verapamil hydrochloride Zydus Pharmaceuticals (USA) Inc. 2026-05-21
68382-0562-01 100 TABLET in 1 BOTTLE (68382-562-01) Verapamil hydrochloride Zydus Pharmaceuticals (USA) Inc. 2026-05-21
68382-0562-05 500 TABLET in 1 BOTTLE (68382-562-05) Verapamil hydrochloride Zydus Pharmaceuticals (USA) Inc. 2026-05-21
68382-0563-01 100 TABLET in 1 BOTTLE (68382-563-01) Verapamil hydrochloride Zydus Pharmaceuticals (USA) Inc. 2026-05-21
68382-0563-05 500 TABLET in 1 BOTTLE (68382-563-05) Verapamil hydrochloride Zydus Pharmaceuticals (USA) Inc. 2026-05-21
68462-0260-01 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462... verapamil hydrochloride Glenmark Pharmaceuticals Inc., USA 2009-09-17
68462-0260-05 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462... verapamil hydrochloride Glenmark Pharmaceuticals Inc., USA 2009-09-17
68462-0260-10 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (6846... verapamil hydrochloride Glenmark Pharmaceuticals Inc., USA 2009-09-17
68462-0260-30 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-... verapamil hydrochloride Glenmark Pharmaceuticals Inc., USA 2009-09-17
68462-0260-90 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-... verapamil hydrochloride Glenmark Pharmaceuticals Inc., USA 2009-09-17
68462-0292-01 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462... verapamil hydrochloride Glenmark Pharmaceuticals Inc., USA 2011-08-05
68462-0292-05 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462... verapamil hydrochloride Glenmark Pharmaceuticals Inc., USA 2011-08-05
68462-0292-90 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-... verapamil hydrochloride Glenmark Pharmaceuticals Inc., USA 2011-08-05
68462-0293-01 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462... verapamil hydrochloride Glenmark Pharmaceuticals Inc., USA 2011-08-05
68462-0293-05 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462... verapamil hydrochloride Glenmark Pharmaceuticals Inc., USA 2011-08-05
68462-0293-90 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-... verapamil hydrochloride Glenmark Pharmaceuticals Inc., USA 2011-08-05
70518-0605-02 50 POUCH in 1 BOX (70518-0605-2) / 1 TABLET, FILM COATED, E... verapamil hydrochloride REMEDYREPACK INC. 2026-04-23
70518-4513-00 90 TABLET in 1 BOTTLE, PLASTIC (70518-4513-0) VERAPAMIL HYDROCHLORIDE REMEDYREPACK INC. 2025-11-01
70771-1953-01 100 TABLET in 1 BOTTLE (70771-1953-1) Verapamil hydrochloride Zydus Lifesciences Limited 2026-05-21
70771-1953-05 500 TABLET in 1 BOTTLE (70771-1953-5) Verapamil hydrochloride Zydus Lifesciences Limited 2026-05-21
70771-1954-01 100 TABLET in 1 BOTTLE (70771-1954-1) Verapamil hydrochloride Zydus Lifesciences Limited 2026-05-21
70771-1954-05 500 TABLET in 1 BOTTLE (70771-1954-5) Verapamil hydrochloride Zydus Lifesciences Limited 2026-05-21
70771-1955-01 100 TABLET in 1 BOTTLE (70771-1955-1) Verapamil hydrochloride Zydus Lifesciences Limited 2026-05-21
70771-1955-05 500 TABLET in 1 BOTTLE (70771-1955-5) Verapamil hydrochloride Zydus Lifesciences Limited 2026-05-21
71205-0607-30 30 TABLET in 1 BOTTLE (71205-607-30) VERAPAMIL HYDROCHLORIDE Proficient Rx LP 2021-09-16
71205-0607-60 60 TABLET in 1 BOTTLE (71205-607-60) VERAPAMIL HYDROCHLORIDE Proficient Rx LP 2021-09-16
71205-0607-90 90 TABLET in 1 BOTTLE (71205-607-90) VERAPAMIL HYDROCHLORIDE Proficient Rx LP 2021-09-16
71209-0047-05 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-047-05) VERAPAMIL HYDROCHLORIDE Cadila Pharmaceuticals Limited 2017-05-27
71209-0047-10 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-047-10) VERAPAMIL HYDROCHLORIDE Cadila Pharmaceuticals Limited 2020-02-14
71209-0048-05 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-048-05) VERAPAMIL HYDROCHLORIDE Cadila Pharmaceuticals Limited 2017-05-27
71209-0048-10 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-048-10) VERAPAMIL HYDROCHLORIDE Cadila Pharmaceuticals Limited 2017-05-27
71209-0104-05 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-104-05) VERAPAMIL HYDROCHLORIDE Cadila Pharmaceuticals Limited 2021-12-27
71209-0104-10 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-104-10) VERAPAMIL HYDROCHLORIDE Cadila Pharmaceuticals Limited 2021-12-27
71335-1258-01 30 TABLET in 1 BOTTLE (71335-1258-1) VERAPAMIL HYDROCHLORIDE Bryant Ranch Prepack 2019-06-03
71335-1258-02 90 TABLET in 1 BOTTLE (71335-1258-2) VERAPAMIL HYDROCHLORIDE Bryant Ranch Prepack 2019-06-03
71335-1258-03 10 TABLET in 1 BOTTLE (71335-1258-3) VERAPAMIL HYDROCHLORIDE Bryant Ranch Prepack 2019-06-03
71610-0405-60 90 TABLET in 1 BOTTLE (71610-405-60) VERAPAMIL HYDROCHLORIDE Aphena Pharma Solutions - Tennessee, LLC 2020-03-18
71610-0405-80 180 TABLET in 1 BOTTLE (71610-405-80) VERAPAMIL HYDROCHLORIDE Aphena Pharma Solutions - Tennessee, LLC 2020-03-18
72789-0416-90 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... verapamil hydrochloride PD-Rx Pharmaceuticals, Inc. 2024-06-19
Observed labelers: Glenmark Pharmaceuticals Inc., USA (11) · Cadila Pharmaceuticals Limited (6) · Zydus Lifesciences Limited (6) · Zydus Pharmaceuticals (USA) Inc. (6) · Bryant Ranch Prepack (3) · Proficient Rx LP (3) · +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.